{"$schema": "https://iptc.org/std/ninjs/ninjs-schema_3.2.json", "uri": "urn:newsml:wireva.mib.news:item:a5a991fb-7a7f-4108-bb43-404658786d61", "type": "text", "profile": "standard", "version": "1", "versioncreated": "2026-10-16T06:40:14.683313Z", "firstcreated": "2026-10-16T06:35:41.957810Z", "pubstatus": "usable", "urgency": 5, "language": "es", "headline": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "byline": "Inés Benítez", "located": "Spain", "copyrightholder": "Haydamax OÜ", "copyrightnotice": "Wireva / Evolut", "usageterms": "Subscribers may republish this item in full, including translation and trimming, with the credit “Wireva / Evolut”. Set rel=canonical to https://evolut.top/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/ when publishing on the web.", "description_text": "Una investigación internacional con participación española observa que una dosis de cabergolina al finalizar la lactancia potencia la involución mamaria y retrasa la aparición de tumores en modelos animales. Datos retrospectivos de más de 150.000 mujeres apuntan en la misma dirección, aunque los científicos insisten en que aún no hay indicación preventiva.", "altids": {"mosaic": "a5a991fb-7a7f-4108-bb43-404658786d61", "story": "2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos"}, "subject": [{"name": "Society", "rel": "direct", "literal": "society", "code": "medtop:14000000", "scheme": "http://cv.iptc.org/newscodes/mediatopic/", "uri": "http://cv.iptc.org/newscodes/mediatopic/14000000"}], "place": [{"name": "Spain", "literal": "es", "code": "ES", "scheme": "http://cv.iptc.org/newscodes/countrycodes/"}], "person": [], "organisation": [], "genre": [{"name": "Standard story", "literal": "standard"}], "service": [{"name": "Wireva", "literal": "wireva"}], "associations": {"featuremedia": {"uri": "urn:newsml:wireva.mib.news:media:a1988cf3-d7cd-472e-a84b-9291931a2a77", "type": "picture", "version": "1", "pubstatus": "usable", "headline": "Un medicamento que frena la lactancia abre un camino inesperado para prevenir el cáncer de mama", "description_text": "Un fármaco para frenar la lactancia reduce a la mitad el cáncer de mama en ratones predispuestos", "copyrightholder": "nbg1.your-objectstorage.com", "copyrightnotice": "Wireva desk", "usageterms": "Supplied with the copy; origin to be confirmed by the desk before redistribution.", "altids": {"wireva": "a1988cf3-d7cd-472e-a84b-9291931a2a77"}, "extra": {"wireva:delivery_mode": "preview_and_link", "wireva:rights": {"licence": "Desk-supplied", "licence_url": "", "licence_raw": "Manual upload", "licence_verified_at": "2026-10-16T08:05:15.924289Z", "attribution_required": true, "attribution_text": "Wireva desk", "redistribution_allowed": false, "commercial_use_allowed": false, "modifications_allowed": false, "share_alike_required": false}, "wireva:provenance": {"creator": "", "source_name": "nbg1.your-objectstorage.com", "source_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "source_page_url": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "our_page_url": "https://claroscuro.fans/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:role": "lead"}, "renditions": {"preview": {"href": "https://nbg1.your-objectstorage.com/ckln/image-assets/56e1c9864948b4491eaa23029ce414a9f73c138d5f0c6580dbfcb309afc9bd8d.jpg", "mimetype": "image/jpeg", "width": 1400, "height": 788}, "source": {"href": "https://nbg1.your-objectstorage.com/ckln/manual-news/trends-156-ES-3.jpg", "mimetype": "image/jpeg"}}}}, "extra": {"wireva:story": {"uri": "urn:newsml:wireva.mib.news:story:2a7a2e1b-0b86-428b-b571-2e086164deac", "slug": "un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016", "status": "updated", "languages": ["es"], "item_count": 3, "is_breaking": false}, "wireva:rights": {"class": "owned", "redistribution_allowed": true, "commercial_use_allowed": true, "modifications_allowed": true, "share_alike_required": false, "attribution_required": true, "attribution_text": "Wireva / Evolut", "canonical_required": true, "canonical_url": "https://evolut.top/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "linkback_required": true, "licence": "Wireva subscriber licence", "licence_url": "", "licensor": "Haydamax OÜ", "valid_until": null, "excerpt_max_chars": 0, "decided_by_rule": "own_production", "needs_review": false}, "wireva:provenance": {"production_method": "ai_assisted", "ai_stages": {"editing": true, "drafting": true, "headline": true, "image_selection": true}, "model": "", "human_reviewed": false, "reviewed_by": "", "reviewed_at": null, "editorial_control": true, "editorial_responsibility": "Haydamax OÜ (Wireva)", "factchecked": false, "verification_status": "unverified", "independent_confirmations": 0, "official_source_used": false, "used_press_release": false, "public_interest": true, "ai_disclosure_required": true, "ai_disclosure_text": "Este artículo se ha producido con ayuda de IA bajo la responsabilidad editorial de Haydamax OÜ.", "independence_check": {"status": "not_applicable", "score": 0.0, "checked_at": "2026-10-16T06:40:14.760230Z"}}, "wireva:publication": {"name": "Evolut", "domain": "evolut.top", "country": "ES", "url": "https://evolut.top/sociedad/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/"}, "wireva:links": {"self": "https://wireva.mib.news/api/v1/items/a5a991fb-7a7f-4108-bb43-404658786d61", "html": "https://wireva.mib.news/item/a5a991fb-7a7f-4108-bb43-404658786d61/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos/", "story": "https://wireva.mib.news/story/un-farmaco-para-frenar-la-lactancia-reduce-a-la-mitad-el-cancer-de-mama-en-ratones-predispuestos-20261016/"}, "wireva:metrics": {"word_count": 614, "char_count": 4159, "reading_time_seconds": 297}}}